Find your next paid study

AtopyPrimary ImmunodeficiencyAutoimmunity+1 more

~$150 – $4,200

Actual pay is set by the research site.

GentiBio, IncNCT06919354

NIAID Centralized Sequencing Protocol

Background: Genetic testing called "sequencing" helps researchers look at DNA. Genes are made of DNA and are the instructions for our bodies to function. We a…

National Institute of Allergy and Infectious Diseases (NIAID)NCT03206099

~$10 – $675

Actual pay is set by the research site.

Observational

Building Resilience in Skilled Nursing Care: Open Pilot for a Behavioral Health Intervention

The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL, for Individuals) for sk…

Nursing Home ResidentSkilled Nursing FacilityDepression+1 more

Massachusetts General HospitalNCT07655232

~$10 – $750

Actual pay is set by the research site.

Chronic Spinal Cord Injury

A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury - A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Trial (RESTORE)

The goal of this clinical trial is to learn if NVG-291 can improve function in adults with chronic cervical motor-incomplete spinal cord injury. It will also l…

NervGen PharmaNCT07799532

~$50 – $2,100

Actual pay is set by the research site.

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Design Trial to Evaluate the Safety and Efficacy of Denifanstat in Participants With Moderate to Severe Acne Vulgaris

The purpose of this study is to evaluate the safety and efficacy of denifanstat compared with matching placebo in participants with moderate to severe acne vul…

Acne Vulgaris

Sagimet Biosciences Inc.NCT07863193

~$50 – $2,100

Actual pay is set by the research site.

Human Papilloma Virus (HPV)High-risk Human Papillomavirus Infection

A Phase 2a, Multi-Center, Placebo-Controlled, Double-Blinded, Randomized, Dose Ranging Study of the Preliminary Efficacy of DARE-HPV to Treat Persistent High-Risk Human Papillomavirus (HPV) Genital Infection

The goal of this clinical study is to learn if DARE-HPV can treat persistent high-risk human papillomavirus (hrHPV). The primary outcome will be if the genital…

Daré Bioscience, Inc.NCT07601074

~$75 – $2,800

Actual pay is set by the research site.

Fasting Hypoglycemia: Diagnosis and Treatment

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients i…

HypoglycemiaInsulinoma

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00001276

~$10 – $675

Actual pay is set by the research site.

Persistent Corneal Epithelial Defect

A Multicenter, Randomized, Double-Masked, Vehicle Controlled Study to Assess the Efficacy and Safety of TP-06 in Participants With Persistent Corneal Epithelial Defects

Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatme…

Tarsus Pharmaceuticals, Inc.NCT07886268

~$75 – $2,800

Actual pay is set by the research site.

Metastatic Castration-resistant Prostate Cancer

A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (d…

~$50 – $2,250

Actual pay is set by the research site.

AmgenNCT07213674

Pulmonary Hypertension Associated With HFpEF

A Multicenter, Open-Label, Long-Term Extension Study for Oral Levosimendan (TNX-103)

The purpose of this study is to provide continued access to treatment with oral levosimendan (TNX-103) and to describe the safety of continued use of TNX-103 i…

Tenax Therapeutics, Inc.NCT07436689

~$50 – $2,100

Actual pay is set by the research site.

A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

This is a multicenter, multinational, randomized, active-controlled, operationally seamless Phase 2/3 study of BMN 333 in treatment-naïve pediatric participant…

Achondroplasia

BioMarin PharmaceuticalNCT07441876

~$75 – $2,800

Actual pay is set by the research site.

Vonescimab for the Treatment of Previously Treated Advanced or Unresectable Leiomyosarcoma - a Phase II Trial

The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unrese…

Leiomyosarcoma